These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6177031)

  • 1. MHC specified lymphocyte activating and suppressor activating determinants in human mixed lymphocyte reactions.
    Fainboim L; Jaraquemada D; Festenstein H; Sachs JA
    Scand J Immunol; 1981 Dec; 14(6):655-67. PubMed ID: 6177031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra HLA-D region recombinant maps HLA-DR between HLA-B and HLA-D.
    Sachs JA; Jaraquemada D; Festenstein H
    Tissue Antigens; 1981 Jan; 17(1):43-56. PubMed ID: 6454280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Split of HLA-D into two regions alpha and beta by a recombination between HLA-D and GLO. I. Study in a family and primed lymphocyte typing for determinants coded by the beta region.
    Mawas C; Charmot D; Mercier P
    Tissue Antigens; 1980 May; 15(5):458-66. PubMed ID: 6160646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anomalous mixed lymphocyte culture reactivity between HLA--A, --B, --C, --DR identical siblings.
    Reinsmoen NL; Noreen HJ; Friend PS; Giblett ER; Greenberg LJ; Kersey JH
    Tissue Antigens; 1979 Jan; 13(1):19-34. PubMed ID: 154195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed lymphocyte reactions for individuals with phenotypic identity for specific HLA-B,DR determinants: the role of linkage disequilibrium and of specific DR and other class II determinants.
    Pollack MS; Chin-Louie J; Callaway C; Blanco MA; Slavin K; Sullivan K; O'Reilly RJ; Dupont B
    J Clin Immunol; 1983 Oct; 3(4):341-51. PubMed ID: 6197424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-linked lymphocyte activating determinants.
    Termijtelen A; van Leeuwen A; van Rood JJ
    Immunol Rev; 1982; 66():79-101. PubMed ID: 6182091
    [No Abstract]   [Full Text] [Related]  

  • 7. Intra HLA-D/DR region recombinant detected by primed lymphocyte typing (PLT).
    Jakobsen BK; Kristensen T; Lamm LU; Morling N; Bruun-Petersen G; Platz P; Ryder LP; Svejgaard A
    Tissue Antigens; 1983 Aug; 22(2):123-33. PubMed ID: 6578608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigens in a psoriatic family: comparative studies with MLC, HTC, PLT and serological HLA-DR determinations.
    Marcusson J; Möller E
    Tissue Antigens; 1979 Oct; 14(4):279-95. PubMed ID: 94702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.
    Chu E; Umetsu D; Rosen F; Geha RS
    J Clin Invest; 1983 Sep; 72(3):1124-9. PubMed ID: 6193142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivity pattern of 15 HLA-Dw1 homozygous typing cells in primary mixed lymphocyte culture.
    Schneider EM; Krupp U; Marchal S; Rittner C
    Hum Genet; 1984; 65(3):242-7. PubMed ID: 6230305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell alloantigens in two recombinant families: prediction of a B/D recombination using B-cell-specific alloantisera.
    Décary F; van Helden-Henningheim L; Westera A; van den Berg-Loonen PM; Engelfriet CP
    Tissue Antigens; 1979 Jan; 13(1):11-8. PubMed ID: 84413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that HLA-D is different from DR and that two different HLA loci code for B-cell antigens.
    Suciu-Foca N; Godfrey M; Rohowsky C; McKiernan P; Susinno E; Broell J
    Transplant Proc; 1979 Dec; 11(4):1781-7. PubMed ID: 93805
    [No Abstract]   [Full Text] [Related]  

  • 13. Occurrence of paternal and maternal HLA-B/D recombinants in a single family.
    Hsu SH; Pollard MK; Bias WB
    Hum Immunol; 1980 Dec; 1(4):325-30. PubMed ID: 6455396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR, D recombination in a kidney transplant recipient.
    Oksenberg JR; Amar A; Cohen N; Cohen T; Brautbar C
    Hum Immunol; 1982 Feb; 4(1):47-53. PubMed ID: 6460723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A suppressor T cell of the mixed lymphocyte reaction specific for the HLA-D region in man.
    Engleman EG; McDevitt HO
    J Clin Invest; 1978 Mar; 61(3):828-38. PubMed ID: 147885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-B/DR recombinant family.
    Mandeville R; Wells L; Dick HM
    Tissue Antigens; 1981 Oct; 18(4):282-4. PubMed ID: 6806939
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary MLC responses of primed lymphocytes after selective sensitization to non-HLA-D determinants.
    Wank R; Schendel DJ; Blanco ME; Dupont B
    Scand J Immunol; 1979; 9(6):499-505. PubMed ID: 88755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LB-Q1 and LB-Q2: two determinants defined in the primed lymphocyte test and independent of HLA-D/DR, MB/LB-E, or SB.
    Termijtelen A; van den Berge SJ; van Rood JJ
    Hum Immunol; 1983 Sep; 8(1):11-5. PubMed ID: 6195131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic control of mixed lymphocyte culture].
    Hajek-Rosenmayr A
    Wien Klin Wochenschr; 1980 Dec; 92(23):834-40. PubMed ID: 6242847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control of immune response to the L-Glu, L-Lys, L-Phe terpolymer in man.
    Chan MM; Bias WB; Hsu SH; Meyers DA
    Am J Hum Genet; 1985 May; 37(3):561-70. PubMed ID: 3923830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.